Full name
VAPOFLOSS PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
58.19.Z - Other publishing activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
73.11.Z - Advertising agencies activities
82.30.Z - Organisation of conventions and trade shows
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 31,8 | 31,8 | 34,9 | 9,7 |
Gross profit (loss) | -23,2 | 3,1 | -8,2 | -366,6 |
Net profit (loss) | -23,2 | 3,1 | -8,2 | -366,6 |
Cash | 4,9 | 4,9 | 4,6 | -5,7 |
Liabilities and provisions for liabilities | 50 | 50 | 50 | 0 |
Net income from sale | 0 | 10 | 0 | -100 |
Short time liabilities | 50 | 50 | 50 | 0 |
Equity capital | -18,2 | -18,2 | -15,1 | 17 |
Working assets | 31,8 | 31,8 | 34,9 | 9,7 |
Operating profit (EBIT) | -23,2 | 3,1 | -1 | -131,6 |
% | % | % | p.p. | |
Profitability of capital | 127,5 | -17 | 54,7 | 71,7 |
Equity capital to total assets | -57 | -57 | -43,1 | 13,9 |
Gross profit margin | 30,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 1825 | 2 147 483 648 | 2 147 481 823 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane